Communiqués Roche Holding AG Swiss Exchange

Actions

Marché Fermé - Swiss Exchange Autres places de cotation 17:30:30 08/05/2026			Varia. 5j.	Varia. 1 janv.
315,30 ^CHF	-0,94%		-0,97%	-3,93%

07/05	Le SMI recule face à l'afflux de résultats ; Swiss Re sous pression	MT
07/05	Bourse : dans quoi investissent nos politiques ?

30/04	Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026	BU
24/04	Genentech Partners With Comedy Icon Damon Wayans and diaTribe to Address Diabetes-Related Vision Loss With ‘All Eyes on DME’ Campaign	BU
22/04	Roche's ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD	AQ
22/04	Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS	BU
21/04	Genentech’s Enspryng (Satralizumab) Reduces Risk of Relapses by 68% Demonstrating Potential to Become First Treatment for MOGAD	BU
21/04	CORRECTING and REPLACING FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus	BU